Description

Cabergoline 0.25mg by ZPHC is a dopamine agonist commonly referenced in clinical and research contexts involving prolactin regulation. It is used in models of hyperprolactinemia and endocrine balance, where suppression of elevated prolactin levels is required to restore hormonal equilibrium.

Active Ingredient and Dosage:
Each tablet contains 0.25 mg of Cabergoline. The product is supplied in a 50-tablet pack designed for controlled and flexible dosing in research or clinical-style protocols.

Usage and Benefits:
Cabergoline is studied for its ability to lower prolactin levels by stimulating dopamine D2 receptors in the hypothalamus and pituitary gland. It is commonly referenced in endocrine models involving prolactin-related dysfunction, and in performance-related contexts where prolactin elevation may contribute to sexual dysfunction or hormonal imbalance.

Mechanism of Action:
Cabergoline acts as a dopamine receptor agonist, inhibiting prolactin secretion from the anterior pituitary gland. This reduction in prolactin levels can help normalize endocrine signaling pathways and support restoration of hormonal balance in research models involving elevated prolactin states.

Product Features:
– Potency: 0.25 mg per tablet
– Presentation: 50-tablet pack for flexible dosing protocols
– Long half-life (approximately 63–69 hours), allowing infrequent dosing schedules
– Oral administration for convenience
– High-purity formulation for consistent response in controlled use

Key Benefits:
– Reduces elevated prolactin levels in endocrine models
– May support improvement in libido and sexual function in prolactin-related conditions
– Assists in restoring hormonal balance during endocrine disruption
– Long-acting profile allows convenient twice-weekly dosing in research protocols
– May contribute to improved mood and well-being through dopamine modulation

Recommended Use:
In research and clinical literature, Cabergoline is commonly referenced at doses of 0.25–0.5 mg twice weekly, depending on prolactin levels and protocol requirements. Dosage is typically adjusted based on hormonal monitoring and individual response.

Possible Side Effects:
– Nausea, vomiting, or gastrointestinal discomfort
– Headache, dizziness, or fatigue
– Lowered blood pressure (monitoring recommended)
– Rare psychiatric effects such as mood changes or compulsive behaviors
– Hormonal shifts with prolonged use requiring monitoring

Contraindications:
Not recommended in individuals with uncontrolled hypertension, severe hepatic disease, or known hypersensitivity to dopamine agonists. Avoid use in pregnancy or breastfeeding unless medically indicated under supervision.

Storage Conditions:
Store in a cool, dry place away from direct sunlight. Keep out of reach of children and pets.